Global Oncology Biosimilars Market Research Report 2016

October 2016 | 131 pages | ID: G1332DC7DEEEN
S&P Consulting

Abstracts

The global oncology biosimilars market will witness substantial growth over the forecast period and is expected to grow at very impressive CAGR during the forecast period. The increasing need for cost-effective treatment methodologies will aid in the stable growth of this market during the forecast period. The high cost of branded biologic oncological drugs will force patients to shift toward biosimilars as they are highly cost-effective. Since biosimilars cost 10%-30% lesser than their parent counterparts, there is the presence of unmet medical needs for such products. This allows domestic manufacturers to market generic versions of the biologic compounds at a lower price, which in turn results in market growth.

Cancer represents a massive burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of several cancer therapeutics has allowed the entry of biosimilars, which are being incorporated into oncology treatment practices. Biosimilars are synthesized with the use of biologic components such as monoclonal antibodies, proteins, hormones, nucleic acids, colony stimulating factors, interleukins, and enzymes. The market offers huge growth opportunities for vendors because of the growing incidence of cancer. The clinical pipeline for cancer biosimilars is vast, featuring candidates in different stages of development. Around 30% of all the biosimilars that are awaiting the US FDA’s approval are monoclonal antibodies, including biosimilars of Avastin, MabThera, and Herceptin.

Factors like the arrival of new biosimilars to drive market growth during the forecast period. Unlike generic drugs, which have APIs that are identical to original drugs, biosimilars are similar to their originator biologic compounds. Biosimilars developed by different manufacturers differ from the original product as well as from each other. Since they are less expensive than biologics, patients will be able to afford and access biosimilars more easily than biologics. Rise in number of patent expiries, increase in prevalence of cancer, growing aging population, promising drug pipeline, need for cost-effective treatment, favorable government regulations are some of the key drivers promoting the growth of oncology biosimilars market.

The Global Oncology Biosimilars Market Research Report 2016 is a valuable source of insightful data for business strategists. It provides the Oncology Biosimilars industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Oncology Biosimilars market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Oncology Biosimilars Market: Regional Segment Analysis

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

The Major players reported in the market include:

• Biocon
• Amgen
• Celltrion
• Hospira
• Biogen
• Mylan
• Pfizer
• Dr. Reddy's Laboratories
• Roche
• GlaxoSmithKline (GSK)
• Merck
• Sanofi and Sandoz.

Global Oncology Biosimilars Market: Product Segment Analysis

• Type I
• Type II
• Type III

Global Oncology Biosimilars Market: Application Segment Analysis

• Application I
• Application II
• Application III

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified SWOT analysis of major market segments

Contents

CHAPTER 1 ONCOLOGY BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Oncology Biosimilars Market Segmentation by Type
  1.2.1 Global Production Market Share of Oncology Biosimilars by Type in 2015
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Oncology Biosimilars Market Segmentation by Application
  1.3.1 Oncology Biosimilars Consumption Market Share by Application in 2015
  1.3.2 Application I
  1.3.3 Application II
  1.3.4 Application III
1.4 Oncology Biosimilars Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Oncology Biosimilars (2011-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON ONCOLOGY BIOSIMILARS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
2.3 Effects to Oncology Biosimilars Industry

CHAPTER 3 GLOBAL ONCOLOGY BIOSIMILARS MARKET COMPETITION BY MANUFACTURERS

3.1 Global Oncology Biosimilars Production and Share by Manufacturers (2015 and 2016)
3.2 Global Oncology Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Oncology Biosimilars Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Oncology Biosimilars Manufacturing Base Distribution, Sales Area and Product Type
3.5 Oncology Biosimilars Market Competitive Situation and Trends
  3.5.1 Oncology Biosimilars Market Concentration Rate
  3.5.2 Oncology Biosimilars Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL ONCOLOGY BIOSIMILARS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

4.1 Global Oncology Biosimilars Production by Region (2011-2016)
4.2 Global Oncology Biosimilars Production Market Share by Region (2011-2016)
4.3 Global Oncology Biosimilars Revenue (Value) and Market Share by Region (2011-2016)
4.4 Global Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
4.5 North America Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
4.6 Europe Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
4.7 China Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
4.8 Japan Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
4.9 Southeast Asia Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
4.10 India Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

CHAPTER 5 GLOBAL ONCOLOGY BIOSIMILARS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

5.1 Global Oncology Biosimilars Consumption by Regions (2011-2016)
5.2 North America Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
5.3 Europe Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
5.4 China Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
5.5 Japan Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
5.6 Southeast Asia Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
5.7 India Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)

CHAPTER 6 GLOBAL ONCOLOGY BIOSIMILARS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Oncology Biosimilars Production and Market Share by Type (2011-2016)
6.2 Global Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
6.3 Global Oncology Biosimilars Price by Type (2011-2016)
6.4 Global Oncology Biosimilars Production Growth by Type (2011-2016)

CHAPTER 7 GLOBAL ONCOLOGY BIOSIMILARS MARKET ANALYSIS BY APPLICATION

7.1 Global Oncology Biosimilars Consumption and Market Share by Application (2011-2016)
7.2 Global Oncology Biosimilars Consumption Growth Rate by Application (2011-2016)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL ONCOLOGY BIOSIMILARS MANUFACTURERS ANALYSIS

8.1 Biocon
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.1.4 Business Overview
8.2 Amgen
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.2.4 Business Overview
8.3 Celltrion
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.3.4 Business Overview
8.4 Hospira
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.4.4 Business Overview
8.5 Biogen
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.5.4 Business Overview
8.6 Mylan
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.6.4 Business Overview
8.7 Pfizer
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.7.4 Business Overview
8.8 Dr. Reddy'sLaboratories
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.8.4 Business Overview
8.9 Roche
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.9.4 Business Overview
8.10 GlaxoSmithKline(GSK)
  8.10.1 Company Basic Information, Manufacturing Base and Competitors
  8.10.2 Product Type, Application and Specification
  8.10.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.10.4 Business Overview
8.11 Merck
8.12 Sanofiand
8.13 Sandoz.

CHAPTER 9 ONCOLOGY BIOSIMILARS MANUFACTURING COST ANALYSIS

9.1 Oncology Biosimilars Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Oncology Biosimilars

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Oncology Biosimilars Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 ANALYSIS OF INVESTMENT STRATEGY

11.1 Industry Development Characters
  11.1.1 Periodicity of the industry
  11.1.2 Regional traits of the industry
  11.1.3 Upstream and downstream of Oncology Biosimilars industry
  11.1.4 Operational mode of the industry
11.2 Analysis of Investment Situation of Oncology Biosimilars Industry
  11.2.1 Development Pattern
  11.2.2 Entry Barrier
  11.2.3 Industrial SWOT Analysis
  11.2.4 Analysis of Industrial Five Forces Mode
11.3 Analysis of Development Trend

CHAPTER 12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

CHAPTER 13 MARKET EFFECT FACTORS ALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

CHAPTER 14 GLOBAL ONCOLOGY BIOSIMILARS MARKET FORECAST (2016-2021)

14.1 Global Oncology Biosimilars Production, Revenue Forecast (2016-2021)
14.2 Global Oncology Biosimilars Production, Consumption Forecast by Regions (2016-2021)
14.3 Global Oncology Biosimilars Production Forecast by Type (2016-2021)
14.4 Global Oncology Biosimilars Consumption Forecast by Application (2016-2021)
14.5 Oncology Biosimilars Price Forecast (2016-2021)

CHAPTER 15 RESEARCH FINDINGS AND CONCLUSION

CHAPTER 16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Figures

LIST OF FIGURES

Figure Picture of Oncology Biosimilars
Figure Global Production Market Share of Oncology Biosimilars by Type in 2015
Figure Application of Oncology Biosimilars
Figure North America Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Oncology Biosimilars Revenue (Million UDS) and Growth Rate (2011-2021)
Figure Global Oncology Biosimilars Capacity of Key Manufacturers in 2015
Figure Global Oncology Biosimilars Capacity of Key Manufacturers in 2016
Figure 2015 Oncology Biosimilars Production Share by Manufacturers
Figure 2016 Oncology Biosimilars Production Share by Manufacturers
Figure Global Market Oncology Biosimilars Average Price of Key Manufacturers in 2015
Figure Oncology Biosimilars Market Share of Top 3 Manufacturers
Figure Oncology Biosimilars Market Share of Top 5 Manufacturers
Figure Global Oncology Biosimilars Capacity Market Share by Regions (2011-2016)
Figure Global Oncology Biosimilars Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Oncology Biosimilars Capacity Market Share by Regions
Figure Global Oncology Biosimilars Production and Market Share by Regions (2011-2016)
Figure Global Oncology Biosimilars Production Market Share by Regions (2011-2016)
Figure 2015 Global Oncology Biosimilars Production Market Share by Regions
Figure Global Oncology Biosimilars Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Oncology Biosimilars Consumption Market Share by Regions
Figure Production Market Share of Oncology Biosimilars by Type (2011-2016)
Figure 2015 Production Market Share of Oncology Biosimilars by Type
Figure Production Revenue Share of Oncology Biosimilars by Type (2011-2016)
Figure 2015 Revenue Market Share of Oncology Biosimilars by Type
Figure Global Oncology Biosimilars Production Growth by Type (2011-2016)
Figure Global Oncology Biosimilars Consumption Market Share by Application in 2015
Figure Global Oncology Biosimilars Consumption Growth Rate by Application (2011-2016)

List Of Tables

LIST OF TABLES

Table Product Overview and Scope of Oncology Biosimilars
Table Major Manufacturers of Type I
Table Major Manufacturers of Type II
Table Major Manufacturers of Type III
Table Oncology Biosimilars Consumption Market Share by Application in 2015
Table Global Oncology Biosimilars Capacity of Key Manufacturers (2015 and 2016)
Table Global Oncology Biosimilars Capacity Market Share by Manufacturers (2015 and 2016)
Table Global Oncology Biosimilars Production of Key Manufacturers (2015 and 2016)
Table Global Oncology Biosimilars Production Share by Manufacturers (2015 and 2016)
Table Global Oncology Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Oncology Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 Global Oncology Biosimilars Revenue Share by Manufacturers
Table Global Market Oncology Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Table Manufacturers Oncology Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Oncology Biosimilars Product Type
Table Global Oncology Biosimilars Capacity by Regions (2011-2016)
Table Global Oncology Biosimilars Production by Regions (2011-2016)
Table Global Oncology Biosimilars Revenue by Regions (2011-2016)
Table Global Oncology Biosimilars Revenue Market Share by Regions (2011-2016)
Table 2015 Global Oncology Biosimilars Revenue Market Share by Regions
Table Global Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table China Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table India Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Oncology Biosimilars Consumption Market by Regions (2011-2016)
Table Global Oncology Biosimilars Consumption Market Share by Regions (2011-2016)
Table North America Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Europe Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table China Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Japan Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table India Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Global Oncology Biosimilars Production by Type (2011-2016)
Table Global Oncology Biosimilars Production Share by Type (2011-2016)
Table Global Oncology Biosimilars Revenue by Type (2011-2016)
Table Global Oncology Biosimilars Revenue Share by Type (2011-2016)
Table Global Oncology Biosimilars Price by Type (2011-2016)
Table Global Oncology Biosimilars Consumption by Application (2011-2016)
Table Global Oncology Biosimilars Consumption Market Share by Application (2011-2016)
Table Global Oncology Biosimilars Consumption Growth Rate by Application (2011-2016)
Table Biocon Basic Information List
Table Biocon Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biocon Oncology Biosimilars Global Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Oncology Biosimilars Global Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celltrion Oncology Biosimilars Global Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira Oncology Biosimilars Global Market Share (2011-2016)
Table Biogen Basic Information List
Table Biogen Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Oncology Biosimilars Global Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mylan Oncology Biosimilars Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Oncology Biosimilars Global Market Share (2011-2016)
Table Dr. Reddy’s Laboratories Basic Information List
Table Dr. Reddy’s Laboratories Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dr. Reddy’s Laboratories Oncology Biosimilars Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Oncology Biosimilars Global Market Share (2011-2016)
Table GlaxoSmithKline (GSK) Basic Information List
Table GlaxoSmithKline (GSK) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline (GSK) Oncology Biosimilars Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Oncology Biosimilars Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Oncology Biosimilars Global Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sandoz Oncology Biosimilars Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Table Key Suppliers of Raw Materials
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Table Four basic brand strategies
Table Industrial SWOT Analysis
Table Global Oncology Biosimilars Production Forecast by Regions (2016-2021)
Table Global Oncology Biosimilars Consumption Forecast by Regions (2016-2021)
Table Global Oncology Biosimilars Production Forecast by Type (2016-2021)
Table Global Oncology Biosimilars Consumption Forecast by Application (2016-2021)